NUCL 98 |
| Ultrasound imaging offers inexpensive portable technology to detect gas-filled microbubbles within the vasculature. Detection of single micron-sized particles (picogram mass) is achieved with existing clinical scanners. Therefore, imaging of targeted ligand-carrying bubbles selectively attached to the regions of upregulation of specific receptors becomes feasible. We prepare stable gas-filled microbubbles stabilized with a lipid monolayer and PEG brush. Particles are outfitted with targeting ligands: antibodies, peptides, carbohydrate derivatives via avidin-biotin link or covalently. Ligand-microbubbles selectively attach to surfaces that present P- or E-selectins, ICAM-1, VCAM-1 or MAdCAM-1. Antibodies allow firm attachment of targeted microbubbles. Rapid binding is necessary to achieve microbubble targeting under flow and can be achieved via PSGL-1 fragments or via polymerized Sialyl Lewis X. In vivo targeting of microbubbles enables delineation and imaging of areas of inflammation. Ultrasound-assisted drug release from microbubble particles allows externally-triggered tissue deposition of pharmaceuticals, which may improve efficacy and specificity of therapeutic interventions. |
|
Recent Advances in Molecular Imaging
1:25 PM-5:00 PM, Wednesday, 13 September 2006 Moscone Center -- Room 272, Oral
Division of Nuclear Chemistry & Technology |